Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation
Using Mapper-based topological data analysis of fMRI during focused-attention and open-monitoring meditation before and after a five-day psilocybin versus placebo retreat in experienced meditators, the study shows that whole-brain activity topology — quantified by optimal transport distance — differentiates meditation styles and psilocybin-induced changes. Crucially, psilocybin-induced positive derealisation paired with enhanced open-monitoring correlated with increased OT distance between open-monitoring and resting state and with greater reported insightfulness, suggesting potential brain markers of beneficial synergy between mindfulness practice and psilocybin.
Authors
- Erich Seifritz
- Milan Scheidegger
- Franz Vollenweider
Published
Abstract
In this study, for the first time, we explored a dataset of functional magnetic resonance images collected during focused attention and open monitoring meditation before and after a five-day psilocybin-assisted meditation retreat using a recently established approach, based on the Mapper algorithm from topological data analysis. After generating subject-specific maps for two groups (psilocybin vs. placebo, 18 subjects/group) of experienced meditators, organizational principles were uncovered using graph topological tools, including the optimal transport (OT) distance, a geometrically rich measure of similarity between brain activity patterns. This revealed characteristics of the topology (i.e. shape) in space (i.e. abstract space of voxels) and time dimension of whole-brain activity patterns during different styles of meditation and psilocybin-induced alterations. Most interestingly, we found that (psilocybin-induced) positive derealization, which fosters insightfulness specifically when accompanied by enhanced open-monitoring meditation, was linked to the OT distance between open-monitoring and resting state. Our findings suggest that enhanced meta-awareness through meditation practice in experienced meditators combined with potential psilocybin-induced positive alterations in perception mediate insightfulness. Together, these findings provide a novel perspective on meditation and psychedelics that may reveal potential novel brain markers for positive synergistic effects between mindfulness practices and psilocybin.
Research Summary of 'Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation'
Introduction
Berit and colleagues situate their work at the intersection of two rapidly expanding literatures: meditation neuroscience and psychedelic research. Earlier studies have documented overlapping phenomenology and some shared neurophysiological signatures between meditation and classical serotonergic psychedelics (e.g. changes in self-consciousness, reduced default mode network activity, altered functional connectivity and increased markers of plasticity). However, most prior work has used conventional measures such as functional connectivity, resting‑state networks, signal variability and entropy. The authors identify a gap: more holistic, geometry‑aware approaches that capture the global spatiotemporal organisation of whole‑brain activity during different meditation styles and under psychedelic influence have not been widely applied to these states. This study applies a topological data analysis (TDA) method based on the Mapper algorithm to fMRI collected before and after a five‑day psilocybin‑assisted meditation retreat in experienced meditators. The authors aim to characterise the ‘‘topological landscape’’ of meditative brain states (focused attention, open monitoring, resting state), test whether psilocybin modulates that landscape, and relate topological descriptors (for example optimal transport distances and graph centrality measures) to subjective reports from an altered‑states questionnaire. They hypothesise that psilocybin will alter the organisation of meditative brain states (consistent with increased informational richness) and that topological measures will relate to experiential dimensions such as meta‑awareness, insightfulness and positive derealization.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topic
- Authors
- APA Citation
Singer, B., Meling, D., Hirsch-Hoffmann, M., Michels, L., Kometer, M., Smigielski, L., Dornbierer, D., Seifritz, E., Vollenweider, F. X., & Scheidegger, M. (2024). Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-55726-x
References (31)
Papers cited by this study that are also in Blossom
Lawrence, D. W., Sharma, B., Griffiths, R. R. et al. · Journal of Psychoactive Drugs (2021)
Hadar, A., David, J., Shalit, N. et al. · Journal of Psychoactive Drugs (2022)
Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Smigielski, L., Kometer, M., Scheidegger, M. et al. · Scientific Reports (2019)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Andersen, K. A. A., Carhart-Harris, R. L., Nutt, D. J. et al. · Acta Psychiatrica Scandinavica (2020)
Luoma, J. B., Chwyl, C., Bathje, G. J. et al. · Journal of Psychoactive Drugs (2020)
Show all 31 referencesShow fewer
Davis, A. K., Barrett, F. S., May, D. G. et al. · JAMA Psychiatry (2021)
Schindowski, E. M., Jungwirth, J., Schuldt, A. et al. · EClinicalMedicine (2023)
Goodwin, G. M., Aaronson, S. T., Alvarez, O. et al. · New England Journal of Medicine (2022)
Gasser, P., Holstein, D., Michel, Y. et al. · Journal of Nervous and Mental Disease (2014)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Johnson, M. W., Garcia-Romeu, A., Griffiths, R. R. · The American Journal of Drug and Alcohol Abuse (2016)
Neil, J. C., Nutt, D. J. · Journal of Psychopharmacology (2022)
Heuschkel, K., Kuypers, K. P. C. · Frontiers in Psychiatry (2020)
Payne, J. E., Chambers, R., Liknaitzky, P. · ACS Pharmacology and Translational Science (2021)
Barrett, F. S., Griffiths, R. R. · Current Topics in Behavioral Neurosciences (2017)
Lebedev, A. V., Kaelen, M., L€ Ovd En, M. et al. · Human Brain Mapping (2016)
Atasoy, S., Leor, R., Kaelen, M. et al. · Scientific Reports (2017)
Herzog, R., Mediano, P. A. M., Rosas, F. E. et al. · Scientific Reports (2023)
McCulloch, D. E-W., Olsen, A. S., Ozenne, B. et al. · MedRvix (2023)
Simonsson, O., Goldberg, S. B. · Journal of Psychoactive Drugs (2022)
Simonsson, A., Simonsson, O., Chambers, R. et al. · Mindfulness (2023)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Journal of Psychopharmacology (2017)
Smigielski, L., Scheidegger, M., Kometer, M. et al. · NeuroImage (2019)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Timmermann, C., Vollenweider, F. X. · Trends in Cognitive Sciences (2023)
Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)
Cited By (5)
Papers in Blossom that reference this study
Garcia-Romeu, A., Naudé, G. P., Rebman, A. W. et al. · Scientific Reports (2026)
Egger, K., Meling, D., Polat, F. et al. · Imaging Neuroscience (2025)
Lewis, B. R., Hendrick, J., Byrne, K. et al. · PLOS Medicine (2025)
Meling, D., Egger, K., Aicher, H. D. et al. · Journal of Psychopharmacology (2024)
Jiwani, Z., Goldberg, S. B., Stroud, J. et al. · MedRvix (2024)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.